Tuesday, 18 June | 0700–1700
Wednesday, 19 June | 0700–1700
Thursday, 20 June | 0700–1200
Tuesday, 18 June | 1015–1800
Wednesday, 19 June | 1015–1545
Joint us after the event for this interactive workshop! You'll be immersed in discussions and real-world case studies that explore how to overcome challenges with emerging solutions in process validation for next-generation bio products.
Explore the exhibitor directory and schedule meetings, plus make sure to take advantage of the opportunities to connect with colleagues in the exhibit hall during the networking breaks.
Add an exclusive facility tour of Takeda Pharmaceuticals or Moderna, Inc. Register today as space is limited. Contact member services at +1-813-960-2105 or visit the event registration desk onsite.
Learn about the practical and regulatory issues that should be considered when developing a facility and process for manufacturing such advanced products.
This Women in Pharma panel of biopharmaceutical leaders will share their insights on achieving and the value of gender balance in biomanufacturing.
Make the most of your professional development by attending in-depth training on 24–26 June in Cambridge. Don't miss this chance to take a deep dive into four critical areas of pharma manufacturing.
Follow the official hashtag of the 2019 ISPE Biopharmaceutical Manufacturing Conference #ISPEBio to stay up to date on what is going on throughout the conference, and use it to share your own experiences on social media.
We welcome your feedback throughout the year on ISPE's continuing education events. A survey will be emailed to all attendees at the close of the conference. Thank you for providing your feedback and ideas for future topics.
Host Sponsor
Gold Sponsor
Silver Sponsor
In the pharmaceutical industry, which is highly regulated, aseptic processing is a critical component that ensures the sterility of products. Regulators have a set of comprehensive requirements that minimize the risk of contamination. Regulators set the requirements; however, the industry has an obligation to the patients who rely on and expect a drug that is safe and free of contamination....
Like any investment in digital manufacturing systems, demonstrating business payback before and after investment is critical to getting MES projects approved and verifying profitability after investment. Whether it is introducing MES, expanding it to additional sites, switching software, upgrading existing software, or developing electronic production records (EPR) for new drug products,...
Sustainability is emerging as a pivotal force influencing the pharmaceutical industry’s dynamics and steering companies towards transformative change. The focus of this analysis is to delve into the sustainability key performance indicators (KPIs) of prominent pharmaceutical players, namely Pfizer, Sanofi, Glaxo Smith Kline (GSK), Becton Dickinson, Johnson & Johnson, Abbott, Eli Lilly, and...